BioLineRx(BLRX)

027-潇湘夜雨2021-12-01 23:05

$BioLineRx(BLRX)$ 万春倒下，你应该雄起啊$万春医药(BYSI)$

财报披露

BioLineRx(BLRX)2021-11-18 20:21

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003640 Act: 34 Size: 970 KB 网页链接

财报披露

BioLineRx(BLRX)2021-11-04 22:21

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003387 Act: 34 Size: 173 KB 网页链接

找寻阳光积极的、可以让生活和世界变得更美好的技术含量高的系列公司6---BLRX

Wisteria-2021-10-14 16:32

BLRX（BioLineRx Ltd） 是一家专注于肿瘤学的以色列临床阶段生物制药公司，其肿瘤学项目包括 Motaxafortide (BL-8040)，这是用于治疗胰腺癌的治疗平台；AGI-134是一种用于多种实体瘤的免疫疗法。 昨天13-Oct-21，BioLineRx 宣布了一项将其 Motixafortide 作为潜在的干细胞动员护理标准的药物经济...

财报披露

BioLineRx(BLRX)2021-10-28 05:12

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003281 Act: 34 Size: 152 KB 网页链接

027-潇湘夜雨2021-10-22 11:49

$BioLineRx(BLRX)$ 最近波动明显加大了，好事将近？

财报披露

BioLineRx(BLRX)2021-10-13 20:42

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003161 Act: 34 Size: 48 KB 网页链接

保密处理信息

BioLineRx(BLRX)2021-09-22 00:18

$BioLineRx(BLRX)$ CT ORDER Confidential treatment order Accession Number: 9999999997-21-004816 Act: 34 Size: 160 KB 网页链接

财报披露

BioLineRx(BLRX)2021-09-04 04:36

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-002928 Act: 34 Size: 324 KB 网页链接

Linktu2021-07-03 03:57

$BioLineRx(BLRX)$ 希望被收购梦想成真

财报披露

BioLineRx(BLRX)05-11 19:18

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001863 Act: 34 Size: 918 KB 网页链接查看全文

年度财报

BioLineRx(BLRX)03-16 19:33

$BioLineRx(BLRX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-22-001134 Act: 34 Size: 12 MB 网页链接查看全文

财报披露

BioLineRx(BLRX)03-16 19:18

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001132 Act: 34 Size: 415 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)03-03 20:18

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000899 Act: 34 Size: 45 KB 网页链接查看全文

超过5%股东持股披露「修订」

BioLineRx(BLRX)02-11 19:57

$BioLineRx(BLRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-006668 Act: 34 Size: 52 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)01-24 20:18

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000197 Act: 34 Size: 40 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)01-18 20:21

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000147 Act: 34 Size: 36 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)2021-12-17 20:18

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003882 Act: 34 Size: 39 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)2021-12-15 20:33

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003868 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)2021-12-04 05:36

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003777 Act: 34 Size: 12 KB 网页链接查看全文

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001863 Act: 34 Size: 918 KB 网页链接

年度财报

$BioLineRx(BLRX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-22-001134 Act: 34 Size: 12 MB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001132 Act: 34 Size: 415 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000899 Act: 34 Size: 45 KB 网页链接

超过5%股东持股披露「修订」

$BioLineRx(BLRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-006668 Act: 34 Size: 52 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000197 Act: 34 Size: 40 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000147 Act: 34 Size: 36 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003882 Act: 34 Size: 39 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003868 Act: 34 Size: 44 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003777 Act: 34 Size: 12 KB 网页链接